Skip to main content
logo
10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
22.68
+0.63 (2.86%)
At close: Jan 21, 2026, 4:00 PM EST
22.75
+0.07 (0.31%)
After-hours: Jan 21, 2026, 7:42 PM EST

10x Genomics Revenue

10x Genomics had revenue of $149.00M in the quarter ending September 30, 2025, a decrease of -1.75%. This brings the company's revenue in the last twelve months to $641.81M, up 1.92% year-over-year. In the year 2024, 10x Genomics had annual revenue of $610.79M, down -1.28%.

Revenue (ttm)
$641.81M
Revenue Growth
+1.92%
P/S Ratio
4.36
Revenue / Employee
$491,435
Employees
1,306
Market Cap
2.87B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024610.79M-7.94M-1.28%
Dec 31, 2023618.73M102.32M19.81%
Dec 31, 2022516.41M25.92M5.28%
Dec 31, 2021490.49M191.65M64.13%
Dec 31, 2020298.85M52.95M21.53%
Dec 31, 2019245.89M99.58M68.06%
Dec 31, 2018146.31M75.23M105.83%
Dec 31, 201771.09M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BrightSpring Health Services13.30B
Teladoc Health2.53B
Privia Health Group2.04B
HealthEquity1.29B
Omnicell1.18B
Waystar Holding1.04B
Doximity621.33M
Hinge Health534.39M
Revenue Rankings

TXG News

More News